Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D5KIL8
|
|||
| Drug Name |
RG6290
|
|||
| Synonyms |
IMC-C103C
Click to Show/Hide
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C00-D48; ICD-9: 140-199] | Phase 1 | [1] | |
| Company |
Immunocore; Roche/Genentech
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03973333) Safety and Efficacy of IMC-C103C as Monotherapy and in Combination With Atezolizumab. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.